A distinctive finding using this approach was the acute-phase response SAA2–SAA4 (SAA2–4) readthrough proteins, whose overrepresentation was associated with nonsevere and severe COVID-19 patients (Figure 7). The gene discussed is SAA2; the disease is COVID-19.